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a  b  s  t  r  a  c  t
A  70-year-old  man  was  referred  to  our  emergency  department  for  shortness  of  breath  on  exertion
and  systemic  edema.  He  had been  taking  lithium  carbonate  for 2 years  (500  mg/day  over  previous  3
months)  for  bipolar  disorder  diagnosed  at age  60. He  was  diagnosed  with  hypothyroidism  accompanied
by  Hashimoto’s  disease  2 weeks  before  hospitalization.  Massive  pericardial  effusion  and bilateral  pleu-
ral effusions  were  demonstrated  by transthoracic  echocardiography  and  computed  tomography.  Cardiac
tamponade  occurred  on  the 3rd  day.  Pericardiocentesis  and  thoracentesis  were  performed  once and
three times,  respectively,  because  of the  acute  deterioration  of  hemodynamic  status  due  to pleural  and
pericardial  effusion.  Lithium  carbonate  is  a widely  used  and  effective  treatment  for  bipolar  disorder.
However,  lithium  has  a narrow  therapeutic  range  and  many  side  effects.  An  important  aspect  of  this  case
was  the  rapid  development  of  severe  hypothyroidism,  although  serum  lithium  concentration  was  mea-
sured  regularly  and  was  maintained  within  the  therapeutic  range.  It is  important  to note  that  lithium  can
cause  serious  complications,  as  in  this  patient,  even  if serum  lithium  concentration  is  measured  regularly
and  maintained  within  the  therapeutic  range.  We  report  the ﬁrst case  of  cardiac  tamponade  caused  by
hypothyroidism  associated  with  administration  of  lithium.
<Learning  objective:  Lithium  carbonate  is  a  widely  used  and  effective  treatment  for  bipolar  disorder.
Goiter  and hypothyroidism  are  common  clinical  side  effects  of  lithium,  but  the  complication  of  cardiac
tamponade  has  not  been  reported.  An  important  aspect  of  this  case  was  the  rapid  development  of  severe
hypothyroidism,  although  serum  lithium  concentration  was  measured  regularly  and  was  maintained
within  the  therapeutic  range.  Therefore,  timely  diagnosis  and treatment  of  hypothyroidism  by  routine
assessment  of  thyroid  function  should  be  performed.>
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Lithium carbonate is a widely used and effective treatment
or bipolar disorder. However, lithium has a narrow therapeutic
ange and many side effects [1]. Pericardial effusion caused by
ypothyroidism is demonstrated by echocardiogram in almost 30%
f patients; however, complications involving cardiac tamponade
re very rare and usually occur in prolonged untreated hypothy-
oidism [2,3]. Goiter and hypothyroidism are common clinical side
ffects of lithium [1,4,5], but the complication of cardiac tampo-
ade has not been reported, to our knowledge. We  report the ﬁrst
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case of cardiac tamponade caused by hypothyroidism associated
with administration of lithium.
Case report
A 70-year-old man  was referred to our emergency depart-
ment for shortness of breath on exertion and systemic edema.
He had been taking lithium carbonate for 2 years (500 mg/day
over previous 3 months) for bipolar disorder diagnosed at age
60. Serum lithium had been maintained in the range of effective
blood concentration from 0.4 to 1.4 mEq/L under monthly moni-
toring (therapeutic range; 0.6–1.2 mEq/L, toxic level > 1.5 mEq/L).
The examination of anemia [hemoglobin (Hb) 9.2 g/dL] revealed
hypothyroidism 3 weeks before hospitalization, although thyroid
function was normal in 2006. He was diagnosed with hypothy-
roidism accompanied by Hashimoto’s disease, because free-T4
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evel was below measurable levels (less than 0.3 ng/dL) and thy-
oid autoantibodies were positive [anti-thyroglobulin antibody
5,000 U/mL, anti-thyroperoxidase antibody (TPO-Ab) 219 U/mL].
ithium was discontinued and levothyroxine sodium 25 g/day
as started under the administration of hydrocortisone 10 mg/day
ne week before hospitalization. On admission, the vital signs
f the patient were as follows: height, 153 cm;  weight, 62 kg;
ody temperature, 36.8 ◦C; blood pressure, 121/81 mmHg  without
aradoxical pulse; heart rate, 78 beats/min with regular rhythm;
espiratory rate, 14 breaths/min; SpO2, 94% (on room air). Phys-
cal examination showed face edema and pitting edema in both
egs. He had diffuse enlargement of the thyroid gland, faint heart
ound without murmurs, and decreased breath sounds in both
ower lung ﬁelds. A blood examination revealed normocytic nor-
ochromic anemia (Hb 9.5 g/dL), slightly low levels of serum
lbumin (3.4 g/dL), elevation of creatine phospholinase (1634 IU/L),
ormal accessory thyroid function, and normal adrenal function.
erum lithium level on admission was below measurable lev-
ls (<0.1 mEq/L). The chest X-ray revealed massive cardiomegaly
Fig. 1A). Electrocardiogram showed normal sinus rhythm and low
oltage in the limb leads. Computed tomography (CT) chest scan
howed massive bilateral pleural effusions and pericardial effusion
Fig. 1B), and echocardiography revealed considerable pericardial
uids. Although levothyroxine was reduced from 25 g/day to
2.5 g/day and hydrocortisone (300 mg/day i.v.) was  adminis-
ered for 2 days, dyspnea was gradually aggravated. On the 3rd
ay, re-examination of echocardiography revealed cardiac tam-
onade (Fig. 2A and B). Five hundred and ﬁfty mL  of pericardial
uids was removed by pericardiocentesis. The cardiac function
fter pericardiocentesis was normal with an ejection fraction of
7%. The removed ﬂuids did not reveal inﬂammatory cells or
alignant cells. In addition, thoracentesis was performed three
imes on the right side and once on the left within 1 week
f hospitalization. Levothyroxine was continued at 12.5 g/day,
nd prednisolone was started at 30 mg/day on day 5 and grad-
ally decreased to 7.5 mg  on the 94th day. Serum free-T4 level
nd thyroid-stimulating hormone (TSH) levels were normalized
n days 17 and 62, respectively. Cardiothoracic ratio improved
rom 69% to 50% (Fig. 3A) and follow-up echocardiographic images
howed absence of pericardial ﬂuids as presented in Fig. 3B on the
2nd day.
He was transferred to a nearby psychiatric hospital on the 35th
ay and has been treated as an outpatient at our hospital.
ig. 1. (A) Chest X-ray on admission showed prominent cardiomegaly and blunting of bi
uantity of pericardial effusion and bilateral pleural effusions.ology Cases 8 (2013) e42–e45 e43
Discussion
Lithium can cause goiter and hypothyroidism, which occur in
approximately 40–50% and 20–30% of patients, respectively [1,4].
In the present patient, thyroid function was examined and found
to be normal in 2006. As no further examination was conducted, it
is unclear whether his thyroid function had already decreased and
thyroid antibody titer was elevated at the start of the treatment
in 2010. Previous clinical studies have shown that lithium exac-
erbates pre-existing autoimmune thyroid disease by accelerating
the increase in thyroid antibody titer, but was not able to produce
thyroid antibodies de novo in humans [4]. Therefore, because of the
high incidence of thyroid dysfunction during lithium treatment,
physical thyroid examination and serum TSH and TPO-Ab titers are
necessary before lithium treatment begins [4,5]. In addition, Boc-
chetta et al. have shown that the annual rate of development of
hypothyroidism was  1.5% in patients on long-term lithium ther-
apy, and that patients with thyroid antibodies had a 6.4% chance
of requiring levothyroxine therapy compared to 0.8% for antibody-
negative patients (relative risk 8.4%) [6]. Considering this increased
prevalence, it was assumed that our patient had a predisposition
for chronic thyroiditis or subclinical hypothyroidism.
In most cases, the symptoms of cardiac tamponade are vague
and not acute because the pericardial effusion forms slowly and
the pericardial sac is able to distend without causing sudden dete-
rioration of cardiac function. The diagnosis is made by detecting
cardiomegaly on chest radiography and is veriﬁed by echocardiog-
raphy. However, in this patient, a chest X-ray was  taken for the ﬁrst
time on the day of hospital transport and the pleural effusion and
cardiac enlargement were noticed for the ﬁrst time.
The Pharmaceuticals and Medical Devices Agency (PMDA) of
Japan published “A request for proper use of lithium carbonate and
measurement of the serum lithium level” on April 9, 2012 [7]. From
April 2006 to November 2011, 98 cases of serious lithium poisoning
were reported to the PMDA.
In our patient, although serum lithium level was main-
tained within the therapeutic range, the patient developed severe
hypothyroidism due to lithium poisoning.
The mechanisms by which lithium causes hypothyroidism and
goiter are considered to be increase of lithium in intrathyroidal
iodine content, inhibition of the coupling of iodotyrosine, and
inhibition of thyroxine release [1]. In our patient, thyroid ultra-
sound showed enlargement of both lobes and a marked increase
lateral costophrenic angles. (B) Chest computed tomography scan revealed a large
















pig. 2. (A) Echocardiogram on the 3rd day revealed massive pericardial effusion an
otion of heart within large effusion. (C) Color Doppler image of thyroid showed a
n blood ﬂow inside the thyroid gland (Fig. 2C). These ﬁndings
how that the activity of the thyroid gland had increased and
upport the mechanism of the impaired secretion of thyroid hor-
one. Thyroid hormone increases myocardial oxygen demand,
hich may  induce ischemic heart disease such as angina pec-
oris or myocardial infarction; therefore, elderly patients and
hose with coronary disease or multiple coronary risk factors
hould initially be treated with levothyroxine at a low dosage
25–50 g daily). In the present patient, as he was  elderly, inter-
al use of levothyroxine was started at a low dosage of 25 g/day
y a previous doctor. However, his symptoms had progressed
nd blood oxygenation had gradually decreased 9 days after the
ig. 3. (A) Chest X-ray on the 62nd day showed normal cardiothoracic ratio and a sharp
ericardial effusion.s of early diastolic right ventricular collapse. (B) Echocardiogram showed swinging
ed increase in blood ﬂow inside the thyroid gland.
start of the replacement. Consequently the symptoms of cardiac
tamponade developed quickly. Therefore, the dosage of levothy-
roxine was decreased from 25 g/day to 12.5 g/day to reduce
myocardial oxygen demand and pericardiocentesis was  immedi-
ately performed to address the decline in stroke volume by cardiac
tamponade. No clear change in thyroid function was observed
after decreasing the dosage from 25 g/day to 12.5 g/day. This
is likely because the dosage of levothyroxine 25 g/day had
only been used for a short period (nine days) during the early
phase of severe hypothyroidism. In hindsight, the differences
between 12.5 g/day and 25 g/day with respect to the effect
of levothyroxine for cardiac tamponade were considered to be
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inor and the reduction of the drug might have been unneces-
ary.
In general, when thyroid dysfunction occurs, lithium therapy
hould not be discontinued, so as to avoid worsening of the psy-
hotic condition [1,4,5]. However, in the present case, because of
he acute deterioration of hemodynamic status due to pleural and
ericardial effusion, it was necessary to stop oral administration of
ithium.
In this patient, levothyroxine could not be stopped and was con-
inued at the same dosage of 12.5 g/day after the withdrawal of
ithium. Thereafter, a reaccumulation of ﬂuid within the pericardial
ac has not occurred one year after pericardiocentesis. The course of
reatment implies that he had a predisposing cause of chronic thy-
oiditis. Therefore, we believe the cause of hypothyroidism was not
nly due to lithium poisoning but also due to chronic thyroiditis.
Since lithium can cause serious complications, as in this patient,
ven if serum lithium concentration is measured regularly and
aintained within the therapeutic range, timely diagnosis and
[
[ology Cases 8 (2013) e42–e45 e45
treatment of hypothyroidism by routine assessment of thyroid
function should be performed.
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